Funding Opportunities: Urgent Competitive Revisions to NIGMS IDeA and NARCH Programs to Address SARS-CoV-2 Vaccine Hesitancy


We’re pleased to announce the availability of supplements to active INBRE (P20), COBRE (P20, P30), IDeA-CTR (U54), and NARCH (S06) awards to support vaccine hesitancy research relevant to SARS-CoV-2. The supplements are aimed at studying the causes of SARS-CoV-2 vaccine hesitancy in IDeA states and/or American Indian/Alaska Native communities, and at developing innovative evidence-based interventions to enhance vaccine acceptance with the goal of increased vaccine uptake.

Applications are due by April 30, 2021; see NOT-GM-21-021 for additional details.

If you have any questions about this supplement opportunity, please contact me.

Submit a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.